Loading…
Based on limited metadata only, ASA Universal Inc., operating as Sonage, received an FDA Warning Letter on November 27, 2018, regarding drug products. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in this metadata. Additional details from the complete Warning Letter would be needed to identify the particular compliance issues cited.